Contraline logo — company profile

Contraline

Founded 2015 United States Charlottesville, United States 22 employees Series A Total: $24.63M Biotechnology, Health Care +1

General Information

Company Name Contraline
Founded Year 2015
Location United States Charlottesville, United States
Employees 22
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Contraline. To contact Contraline, visit contraline.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Contraline

Contraline is a venture-backed, clinical-stage biotechnology company founded in 2015, based in the United States. Specializing in the Biotechnology and Health Care industries, Contraline is focused on developing the first long-lasting, non-hormonal, and reversible male contraceptive. Their innovative approach has attracted attention and investment, with the most recent funding round taking place on 12 December 2022, with investment coming from Talent Resources Ventures. As they continue to make strides in this critical area of healthcare, Contraline's unique position in the market and recent investment make it a compelling prospect for potential venture capital interest.

Taxonomy: medical device, urology, contraception, women's health, reproductive health, men's health

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $7.20M 8
GV, Amboy Street Ventures +6
10 Nov 2022
Series A $10.70M 10
Founders Fund, Launch +8
20 Oct 2021
Grant $600.00K 1
Virginia Catalyst
26 Oct 2020
Venture Round Undisclosed 3
VU Venture Partners, Bioverge Ventures +1
27 Apr 2020
Grant $200.00K -
24 Jan 2019
Seed Round $3.00M 10
Kima Ventures, Founders Fund +8
18 Sep 2018
Seed Round $2.25M 8
Founders Fund, Launch +6
31 Mar 2017
Pre Seed Round $680.00K 3
Kima Ventures, Jaffray Woodriff +1
01 Jun 2016

Contraline Alternatives & Competitors

View All Alternatives
Contraline vs
Paterna Biosciences
Paterna Biosciences United States

From infertility to fatherhood

Seed
23 employees
Biotechnology, Health Care
Contraline vs
Celmatix
Celmatix United States

A preclinical-stage women’s health biotech focused uniquely on ovarian biology.

Venture round
24 employees
Biotechnology, Health Care
Contraline vs

The Stork Ib2C, A Rinovum Women’s Health Company is a women’s health company dedicated to bringing p...

Series C
3 employees
Health Care, Medical Devices

FAQ About Contraline

Contraline is a venture-backed, clinical-stage biotechnology company at the forefront of male contraception.
Contraline was founded in 2015.
Contraline is headquartered in Charlottesville, United States.
Contraline operates in Biotechnology, Health Care and Medical Devices. Its work centres on medical device, urology, contraception and women's health.
Contraline has approximately 22 employees.
Contraline has completed 8 funding rounds, raising a total of $24.63M. The latest funding stage is Series A.
Top alternatives and competitors to Contraline include Paterna Biosciences, Celmatix, The Stork Ib2C, A Rinovum Women's Health Company, Mithra, inne. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Contraline and Paterna Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Contraline, https://bouncewatch.com/company/contraline, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes